We are grateful for our team’s dedication and this significant achievement.
ABX-CRO is proud to announce the successful completion of an FDA pre-approval inspection for a PET radiodiagnostic with a biological pharmacophore of a global phase III trial conducted by ABX-CRO, highlighting our unique expertise bringing innovative radiopharmaceuticals to the market.
We are grateful for our team’s dedication and this significant achievement.
ABX-CRO is proud to announce the successful completion of an FDA pre-approval inspection for a PET radiodiagnostic with a biological pharmacophore of a global phase III trial conducted by ABX-CRO, highlighting our unique expertise bringing innovative radiopharmaceuticals to the market.